Nissa M. Westerberg

Array ( [id] => 20287239 [patent_doc_number] => 20250312482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => LIPID NANOPARTICLES FOR THE TREATMENT OF VASCULAR DISEASES [patent_app_type] => utility [patent_app_number] => 19/171160 [patent_app_country] => US [patent_app_date] => 2025-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14141 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19171160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19989534 [patent_doc_number] => 20250127756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 19/005409 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19989535 [patent_doc_number] => 20250127757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 19/005427 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19989534 [patent_doc_number] => 20250127756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 19/005409 [patent_app_country] => US [patent_app_date] => 2024-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19005409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19752871 [patent_doc_number] => 20250041436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells [patent_app_type] => utility [patent_app_number] => 18/904575 [patent_app_country] => US [patent_app_date] => 2024-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18904575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19629829 [patent_doc_number] => 20240408278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => RAPID FORMING ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD [patent_app_type] => utility [patent_app_number] => 18/812148 [patent_app_country] => US [patent_app_date] => 2024-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18812148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19570312 [patent_doc_number] => 20240374604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/787389 [patent_app_country] => US [patent_app_date] => 2024-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18787389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19707924 [patent_doc_number] => 20250018066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => Ophthalmic dye composition [patent_app_type] => utility [patent_app_number] => 18/772309 [patent_app_country] => US [patent_app_date] => 2024-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19707924 [patent_doc_number] => 20250018066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => Ophthalmic dye composition [patent_app_type] => utility [patent_app_number] => 18/772309 [patent_app_country] => US [patent_app_date] => 2024-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784310 [patent_doc_number] => 20250057989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS [patent_app_type] => utility [patent_app_number] => 18/766083 [patent_app_country] => US [patent_app_date] => 2024-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18766083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784316 [patent_doc_number] => 20250057995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR [patent_app_type] => utility [patent_app_number] => 18/732745 [patent_app_country] => US [patent_app_date] => 2024-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784316 [patent_doc_number] => 20250057995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => RADIOLIGANDS FOR IMAGING THE LPA1 RECEPTOR [patent_app_type] => utility [patent_app_number] => 18/732745 [patent_app_country] => US [patent_app_date] => 2024-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830177 [patent_doc_number] => 20250081963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => ANTIMICROBIAL AND DRUG-NEUTRALIZING COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/640861 [patent_app_country] => US [patent_app_date] => 2024-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830177 [patent_doc_number] => 20250081963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => ANTIMICROBIAL AND DRUG-NEUTRALIZING COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/640861 [patent_app_country] => US [patent_app_date] => 2024-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13193 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19656137 [patent_doc_number] => 20240423202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => ANTIMICROBIAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/624853 [patent_app_country] => US [patent_app_date] => 2024-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8869 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18624853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20048135 [patent_doc_number] => 20250186357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => SUPRAMOLECULAR IONIZABLE LIPID MOLECULES WITH HETEROATOMIC TUNING FOR NUCLEIC ACID DELIVERY [patent_app_type] => utility [patent_app_number] => 18/621526 [patent_app_country] => US [patent_app_date] => 2024-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19234 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19402066 [patent_doc_number] => 20240285577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 18/611564 [patent_app_country] => US [patent_app_date] => 2024-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18611564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19263496 [patent_doc_number] => 20240207193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => CHEMICAL COMPOSITION FOR ENTERIC DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 18/600459 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4973 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19263496 [patent_doc_number] => 20240207193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => CHEMICAL COMPOSITION FOR ENTERIC DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 18/600459 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4973 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19263719 [patent_doc_number] => 20240207416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY [patent_app_type] => utility [patent_app_number] => 18/424697 [patent_app_country] => US [patent_app_date] => 2024-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10459 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424697 [rel_patent_id] =>[rel_patent_doc_number] =>)